CMMB
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Chemomab presents positive Phase 2 clinical data for Nebokitug in primary sclerosing cholangitis at BSG Live'25Jun 30, 2025
- Chemomab receives positive FDA feedback supporting Phase 3 development of Nebokitug for PSCJun 11, 2025
- Chemomab announces new patents for Nebokitug, a first-in-class therapy targeting primary sclerosing cholangitisJun 3, 2025